Visual field characteristics in neuromyelitis optica in absence of and after one episode of optic neuritis

Clinical Ophthalmology

Volumn 7, Issue , 2013, Pages 1145-1153

  Merle, Harold ^a   Olindo, Stéphane ^b   Jeannin, Séverine ^b   Hage, Rabih ^a   Donnio, Angélique ^a   Richer, Raymond ^a   Cabre, Philippe ^b  

^a Service d'Ophtalmologie   (France)

^b CENTRE HOSPITALIER UNIVERSITAIRE DE FORT DE FRANCE   (France)

Author keywords

Multiple sclerosis; Neuromyelitis optica; Optic neuritis; Visual field

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMPHREY PERIMETER; MALE; MULTIPLE SCLEROSIS; MYELOOPTIC NEUROPATHY; OPTIC NEURITIS; PERIMETRY; PREDICTIVE VALUE; VISUAL ACUITY; VISUAL FIELD DEFECT;

EID: 84879036455     PISSN: 11775467     EISSN: 11775483     Source Type: Journal    
DOI: 10.2147/OPTH.S43894     Document Type: Article

References (31)

1. Devic E. Myélite subaiguë compliquée de névrite optique. Bull Méd. 1894;8:1033-1034.
2. Wingerchuk DM, Lennon VA, Lucchinetti CF, Pittock SJ, Weinshenker BG.The spectrum of neuromyelitis optica. Lancet Neurol. 2007;6 (9): 805-815.
3. Lennon VA, Kryzer TJ, Pittock SJ, Verkman AS, Hinson SR. Ig G marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med. 2005;202 (4):473-477.
4. Lennon VA, Wingerchuk DM, Kryser TJ, et al. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet. 2004;364 (9451):2106-2112.
5. Lucchinetti CF, Mandler RN, McGavern D, et al. A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica. Brain. 2002;125 (Pt 7):1450-1461.
6. Merle H, Olindo S, Bonnan M, et al. Natural history of the visual impairment of relapsing neuromyelitis optica. Ophthalmology. 2007; 114 (4):810-815.
7. Hickman SJ, Dalton CM, Miller DH, Plant GT. Management of acute optic neuritis. Lancet. 2002;360 (9349):1953-1962.
8. Watanabe S, Nakashima I, Misu T, et al. Therapeutic efficacy of plasma exchange in NMO-IgG-positive patients with neuromyelitis optica. Mult Scler. 2007;13 (1):128-132.
9. Yoshida H, Ando A, Sho K, et al. Anti-aquaporin-4 antibody-positive optic neuritis treated with double-filtration plasmapheresis. J Ocul Pharmacol Ther. 2010;26 (4):381-385.
10. Merle H, Olindo S, Jeannin S, et al. Treatment of optic neuritis by plasma exchange (add-on) in neuromyelitis optica. Arch Ophthalmol. 2012;130 (7):858-862.
11. Wingerchuk DM, Hogancamp WF, O'Brien PC, Weinshenker BG. The clinical course of neuromyelitis optica (Devic's syndrome). Neurology. 1999;53 (5):1107-1114.
12. Wingerchuk DM, Lennon VA, Pittock SJ, et al. Revised diagnostic criteria for neuromyelitis optica. Neurology. 2006;66 (10):1485-1489.
13. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: a expanded disability status scale (EDSS). Neurology. 1983;33 (11): 1444-1452.
14. McDonald WI, Compston A, Edan G, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnoses of multiples sclerosis. Ann Neurol. 2001;50 (1): 121-127.
15. Trobe JD, Beck RW, Moke PS, Cleary PA. Contrast sensitivity and other vision tests in the optic neuritis treatment trial. Am J Ophthalmol. 1996;121(5):547-553.
16. Keltner JL, Johnson CA, Cello KE, Dontchev M, Gal RL, Beck RW; Optic Neuritis Study Group. Visual field profile of optic neuritis. A final follow-up report from the optic neuritis treatment trial from baseline through 15 years. Arch Ophthalmol. 2010;128 (3):330-337.
17. Fernandes DB, Ramos Rde I, Falcochio C, Apóstolos-Pereira S, Callegaro D, Monteiro ML. Comparison of visual acuity and automated perimetry findings in patients with neuromyelitis optica or multiple sclerosis after single or multiple attacks of optic neuritis. J Neuroophthalmol. 2012;32 (2):102-106.
18. Waters P, Jarius S, Littleton E, et al. Aquaporin-4 antibodies in neuromyelitis optica and longitudinally extensive transverse myelitis. Arch Neurol. 2008;65 (7):913-919.
19. McDonald WI, Barnes D. The ocular manifestations of multiple sclerosis. 1. Abnormalities of the afferent visual system. J Neurol Neurosurg Psychiatry. 1992;55 (9):747-752.
20. Slamovits TL, Rosen CE, Cheng KP, Striph GG. Visual recovery in patients with optic neuritis and visual loss to no light perception. Am J Ophthalmol. 1991;111 (2):209-214.
21. Osuntokun BO. The pattern of neurological illness in tropical Africa. Experience at Ibadan, Nigeria. J Neurol Sci. 1971;12 (4):417-442.
22. Kira J. Multiple sclerosis in the Japanese population. Lancet Neurol. 2003;2 (2):117-127.
23. Naismith RT, Tutlam NT, Xu J, et al. Optical coherence tomography differs in neuromyelitis optica compared with multiple sclerosis. Neurology. 2009;72 (12):1077-1082.
24. Merle H, Olindo S, Donnio A, Richer R, Smadja D, Cabre P. Retinal peripapillary nerve fiber layer thickness in neuromyelitis optica. Invest Ophthalmol Vis Sci. 2008;49(10):4412-4417.
25. Wang KC, Wang SJ, Lee CL, Chen SY, Tsai CP. The rescue effect of plasma exchange for neuromyelitis optica. J Clin Neurosci. 2011; 18 (1):43-46.
26. Nakajima H, Hosokawa T, Sugino M, et al. Visual field defects of optic neuritis in neuromyelitis optica compared with multiple sclerosis. BMC Neurol. 2010;10:45.
27. Sadda SR, Nee M, Miller NR, Biousse V, Newman N, Kouzis A. Clinical spectrum of posterior ischemic optic neuropathy. Am J Ophthalmol. 2001;132 (5):743-750.
28. Mandler RN, Davis LE, Jeffery DR, Kornfeld M. Devic's neuromyelitis optica: a clinicopathological study of 8 patients. Ann Neurol. 1993;34 (2): 162-168.
29. Fardet L, Généreau T, Mikaeloff Y, Fontaine B, Seilhean D, Cabane J. Devic's neuromyelitis optica: study of nine cases. Acta Neurol Scand. 2003;108 (3):193-200.
30. Green AJ, Cree BA. Distinctive retinal nerve fibre layer and vascular changes in neuromyelitis optica following optic neuritis. J Neurol Neurosurg Psychiatry. 2009;80 (9):1002-1005.
31. Roemer SF, Parisi JE, Lennon VA, et al. Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis. Brain. 2007;130 (Pt 5):1194-1205.